Intermap Reports Low Q1 Revenue, Reaffirms Ambitious Full-Year Guidance
ITMSF sits 68% above its 52-week low of $0.87.
Summary
Intermap reported Q1 2026 revenue of $1.4 million, but reaffirmed its full-year guidance of $30-35 million, signaling expected significant revenue acceleration from government contracts.
Key Events · Earnings and Guidance · ITMSF
-
Q1 2026 Revenue Reported
Total revenue for the first quarter ended March 31, 2026, was $1.4 million.
-
Recurring Revenue Exceeds 80%
Recurring subscription and data revenue represented more than 80% of total revenue for the quarter.
-
Full-Year 2026 Guidance Reaffirmed
The company reiterated its previously announced 2026 guidance of $30-35 million in revenue and a 28% EBITDA margin, despite the low Q1 revenue.
-
Strong Liquidity Position
Intermap ended the quarter with approximately $18.8 million in cash and $16.3 million in working capital.
Analysis · ITMSF · Technology
Intermap's Q1 2026 revenue of $1.4 million was significantly lower than the implied run rate for its full-year guidance of $30-35 million. However, management reiterated this guidance, indicating strong confidence in converting its government pipeline and accelerating revenue in subsequent quarters. The company also highlighted over 80% recurring revenue and a healthy cash position, suggesting operational stability despite the slow start to the year.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.2% of the 1581 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ITMSF was trading at $1.47 on OTC in the Technology sector, with a market capitalization of approximately $106.3M. The 52-week trading range was $0.87 to $2.60. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.